These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 26258149)

  • 1. Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients.
    Bank JR; Rabelink TJ; de Fijter JW; Reinders ME
    J Immunol Res; 2015; 2015():391797. PubMed ID: 26258149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study.
    Pan GH; Chen Z; Xu L; Zhu JH; Xiang P; Ma JJ; Peng YW; Li GH; Chen XY; Fang JL; Guo YH; Zhang L; Liu LS
    Oncotarget; 2016 Mar; 7(11):12089-101. PubMed ID: 26933811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study.
    Reinders ME; Dreyer GJ; Bank JR; Roelofs H; Heidt S; Roelen DL; Zandvliet ML; Huurman VA; Fibbe WE; van Kooten C; Claas FH; Rabelink TJ; de Fijter JW
    J Transl Med; 2015 Nov; 13():344. PubMed ID: 26537851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical translation of multipotent mesenchymal stromal cells in transplantation.
    Leuning DG; Reinders ME; de Fijter JW; Rabelink TJ
    Semin Nephrol; 2014 Jul; 34(4):351-64. PubMed ID: 25217264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients.
    Reinders ME; Bank JR; Dreyer GJ; Roelofs H; Heidt S; Roelen DL; Al Huurman V; Lindeman J; van Kooten C; Claas FH; Fibbe WE; Rabelink TJ; de Fijter JW
    J Transl Med; 2014 Dec; 12():331. PubMed ID: 25491391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study.
    Peng Y; Ke M; Xu L; Liu L; Chen X; Xia W; Li X; Chen Z; Ma J; Liao D; Li G; Fang J; Pan G; Xiang AP
    Transplantation; 2013 Jan; 95(1):161-8. PubMed ID: 23263506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mesenchymal stromal cells in chronic transplant rejection after solid organ transplantation.
    Reinders ME; Rabelink TJ; de Fijter JW
    Curr Opin Organ Transplant; 2013 Feb; 18(1):44-50. PubMed ID: 23254697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation.
    Merino A; Ripoll E; de Ramon L; Bolaños N; Goma M; Bestard O; Lloberas N; Grinyo JM; Ambròs JT
    Cell Transplant; 2017 Jun; 26(6):1017-1030. PubMed ID: 28160460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.
    Reinders ME; de Fijter JW; Roelofs H; Bajema IM; de Vries DK; Schaapherder AF; Claas FH; van Miert PP; Roelen DL; van Kooten C; Fibbe WE; Rabelink TJ
    Stem Cells Transl Med; 2013 Feb; 2(2):107-11. PubMed ID: 23349326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis.
    Zhao L; Hu C; Han F; Chen D; Cheng J; Wu J; Peng W; Chen J
    Stem Cell Res Ther; 2021 Mar; 12(1):158. PubMed ID: 33648596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stromal cells and hematopoietic stem cell transplantation.
    Bernardo ME; Fibbe WE
    Immunol Lett; 2015 Dec; 168(2):215-21. PubMed ID: 26116911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.
    Tan J; Wu W; Xu X; Liao L; Zheng F; Messinger S; Sun X; Chen J; Yang S; Cai J; Gao X; Pileggi A; Ricordi C
    JAMA; 2012 Mar; 307(11):1169-77. PubMed ID: 22436957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance.
    Franquesa M; Hoogduijn MJ; Baan CC
    Curr Opin Organ Transplant; 2012 Aug; 17(4):355-61. PubMed ID: 22710385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival.
    Koch M; Lehnhardt A; Hu X; Brunswig-Spickenheier B; Stolk M; Bröcker V; Noriega M; Seifert M; Lange C
    Transpl Immunol; 2013 Dec; 29(1-4):43-50. PubMed ID: 23994720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cell-based therapy in kidney transplantation.
    Chen C; Hou J
    Stem Cell Res Ther; 2016 Feb; 7():16. PubMed ID: 26852923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.
    Perico N; Casiraghi F; Gotti E; Introna M; Todeschini M; Cavinato RA; Capelli C; Rambaldi A; Cassis P; Rizzo P; Cortinovis M; Noris M; Remuzzi G
    Transpl Int; 2013 Sep; 26(9):867-78. PubMed ID: 23738760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study.
    Detry O; Vandermeulen M; Delbouille MH; Somja J; Bletard N; Briquet A; Lechanteur C; Giet O; Baudoux E; Hannon M; Baron F; Beguin Y
    J Hepatol; 2017 Jul; 67(1):47-55. PubMed ID: 28284916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
    Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
    Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.